Ongoing trials continue to explore benefits that extend well beyond weight, including reductions in major cardiovascular events, slower progression of chronic kidney disease, and preliminary signals in Alzheimers and addiction research
Additionally, it has been shown to reduce inflammation in the gut often associated with diseases like leaky gut syndrome and inflammatory bowel disease
Since endometriosis and adenomyosis often coexist, it is possible that the adverse pregnancy outcomes attributed to endometriosis in this study were actually influenced by the presence of adenomyosis
TL;DR: In a large sample of US Veterans, GLP-1 drugs were associated with reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions, but increased risk of gastrointestinal issues, hypotension (low blood pressure), and some kidney-related conditions